For each of the patients below, identify the most appropriate clinical preventive action based on current United States Preventive Services Task Force (USPSTF) guidelines.
- A 71-year-old male presenting for an annual wellness exam. He denies any current tobacco use but reports he smoked a total of approximately 150 cigarettes during a stressful period in his early 20s. He has not had any previous vascular screening tests.Perform one-time screening with abdominal ultrasonography.
- A 36-year-old healthy female of Ashkenazi Jewish descent presenting for a routine check-up. She has absolutely no known personal or family history of any malignancies.Administer a brief familial risk assessment tool for genetic susceptibility.
- A 67-year-old female presenting to establish care. She underwent a loop electrosurgical excision procedure for cervical intraepithelial neoplasia (CIN) 3 at age 54. Her records document three consecutive negative HPV and cytology cotests over the past decade.Continue routine screening with primary HPV testing, cytology, or cotesting.
- A 54-year-old male presenting for a physical. He has a 35-pack-year smoking history but successfully quit all tobacco products exactly 16 years ago. He is up to date on his colorectal cancer screening.Withhold low-dose computed tomography (LDCT) of the chest.
Cevap
The 71-year-old male matches with one-time abdominal ultrasonography. The 36-year-old female matches with the brief familial risk assessment tool. The 67-year-old female matches with continued routine cervical screening. The 54-year-old male matches with withholding low-dose computed tomography of the chest.
This matching set tests high-yield exceptions and strict thresholds in USPSTF guidelines. The 71-year-old male requires AAA screening because the 'ever smoked' criteria is precisely defined as 100 or more lifetime cigarettes. The 36-year-old female requires a brief familial risk assessment tool because Ashkenazi Jewish ancestry alone is a sufficient trigger, regardless of her lack of family history. The 67-year-old female must continue cervical cancer screening because a history of CIN 2 or 3 mandates 20 years of continued screening after treatment, superseding the typical age-65 stop date. Finally, the 54-year-old male does not qualify for lung cancer screening because the benefit of LDCT is no longer supported once smoking cessation occurred more than 15 years ago.
Adım Adım Çözüm
Anahtar Kavram
Nuanced exceptions and strict numerical thresholds in USPSTF Grade A and B clinical preventive screening guidelines.